Distribution of β-thalassemia mutations in the northern provinces of Iran

Hemoglobin

Volumn 31, Issue 3, 2007, Pages 351-356

  Derakhshandeh Peykar, Pupak ^a,b   Akhavan Niaki, Haleh ^c   Tamaddoni, Ahmad ^c   Ghawidel Parsa, Shohreh ^d   Naieni, Kourosh Holakouie ^e   Rahmani, Manijeh ^b   Babrzadeh, Farbod ^b   Dilmaghani Zadeh, Mohammad ^a   Farhud, Dariush Daneshvar ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Dr Farhud Genetic Clinic   (Iran)

^c BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d Division of Neonatology   (Iran)

^e UNIVERSITY OF TEHRAN   (Iran)

Author keywords

Globin mutation; Thalassemia (thal); Reverse dot blot

Indexed keywords

GENOMIC DNA;

ARTICLE; BETA THALASSEMIA; CONTROLLED STUDY; DISEASE CONTROL; DNA ISOLATION; FEMALE; FRAMESHIFT MUTATION; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; HEMATOLOGICAL PROCEDURES; HUMAN; IRAN; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRENATAL DIAGNOSIS;

BETA-THALASSEMIA; DNA MUTATIONAL ANALYSIS; EPIDEMIOLOGY, MOLECULAR; FEMALE; FRAMESHIFT MUTATION; GENE FREQUENCY; HUMANS; IRAN; MALE; MUTATION; POINT MUTATION; PREGNANCY; SEQUENCE DELETION;

EID: 34547187703     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260701462030     Document Type: Article

References (23)

1. Olivieri NF. The β-thalassemias. N Engl J Med 1999; 341(2):99-109.
2. Najmabadi H, Karimi-Nejad R, Sahebjam S, Pourfarzad F, Teimourian S, Sahebjam F, Amirizadeh N, Karimi-Nejad MH. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin 2001; 25(3):285-296.
3. Najmabadi H, Pourfathollah AA, Neishabury M, Sahebjam F, Krugluger W, Oberkanins C. Rare and unexpected mutations among Iranian β-thalassemia patients and prenatal samples discovered by reverse-hybridization and DNA sequencing. Haematologica 2002; 87(10):1113-1114.
4. Nozari G, Rahbar S, Darbre P, Lehmann H. Hemoglobin Setif (α94 (G1) Asp→Tyr) in Iran. A report of 9 cases. Hemoglobin 1977; 1(3):289-291.
5. Habibi Roudknar M, Najmabadi H, Derakhshandeh P, Farhud DD. Detection of rare and unknown mutations in β-thalassemia traits in Iran. Iranian J Publ Health 2003; 32(1):1-14.
6. Yavarian M, Harteveld CL, Batelaan D, Bernini LF, Giordano PC. Molecular spectrum of β-thalassemia in the Iranian province of Hormozgan. Hemoglobin 2001; 25(1):35-43.
7. Mahboudi F, Zeinali S, Merat A, Delmaghani S, Mostafavipour K, Moghaddam Z, Haghshenas M. The molecular basis of β-thalassemia mutations in Fars Province, Iran. Iran J Med Sci 1996; 21(3&4):99-104.
8. Merat A, Haghshenas M, Mostafavi Pour Z, Plonczynski MW, Harrel AN, Coleman MB, Steinberg MH. β-Thalassemia in Southwestern Iran. Hemoglobin 1993; 17(5):427-437.
9. Merat A, Haghshenas M. The spectrum of β-thalassemia mutations in Iran. Med J I R Iran 2000; 14(1):103-106.
10. Noori-Daloii MR, Moazami N, Farhangi S, Atalay A, Geren IN, Akar L, Atalay EO, Çirakoglu B, Bermek E. β-Thalassemia in Iran: a high incidence of the nonsense codon 39 mutation on the island of Queshm. Hemoglobin 1994; 18(6):449-453.
11. Najmabadi H, Ghamar A, Sahebjam F, Kariminejad R, Hadavi V, Khatibi T, Samavat A, Mehdipour E, Modell B, Kariminejad MH. Fourteen-year experience of prenatal diagnosis of thalassemia in Iran. Commun Genet 2006; 9(2):93-97.
12. Haldane J. The rate of mutations of human genes. Hereditas 1949; 35(Suppl):267-273.
13. Pattanapanyasat K, Yongvanitchit K, Tongtawe P, Tachavanich K, Wanachiwananwin W, Fucharoen S, Walsh DS. Impairment of Plasmodium falciparum growth in thalassemic red blood cells: further evidence by using biotin labeling and flow cytometry. Blood 1999; 93(9):3116-3119.
14. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular weight DNA from mammalian cells. Eur J Biochem 1973; 36(1):32-38.
15. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleotide cells. Nucleic Acids Res 1988; 16(3):1215.
16. Makrydimas G, Georgiou I, Kranas V, Zikopoulos K, Lolis D. Prenatal diagnosis of β-thalassemia by coelocentesis. Mol Hum Reprod 1997; 3(8):729-731.
17. Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutation in DNA; the amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17(7):2503.
18. Maggio A, Giambona A, Cai SP, Wall J, Kan YW, Chehab FF. Rapid and simultaneous typing of Hemoglobin S, Hemoglobin C, and seven Mediterranean β-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood 1993; 81:(1)239-242.
19. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 2002; 19(3):225-233 (http://globin.cse.psu.edu).
20. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DHK, Anagnou NP, Wajcman H, Hardison RC. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 2004; 32(Database issue):D537-D541 (http://globin.cse.psu.edu).
21. Huisman THJ, Carver MFH, Baysal E. A Syllabus of Thalassemia Mutations (1997). Augusta: The Sickle Cell Anemia Foundation. 1997 (http://globin.cse.psu. edu).
22. Asadi AA, Doroudchi. Thalassemia major and consanguinity in Shiraz City, Iran. Turk J Haematol 2004; 21(3):127-130.
23. Samavat A, Modell B. Iranian national thalassaemia screening programme. Br Med J 2004; 329(7475):1134-1137.